Literature DB >> 21255445

Endoscopic treatment of vesicoureteral reflux using calcium hydroxyl apatite in dogs.

Jalal Bakhtiari1, Abdol Mohammad Kajbafzadeh, Mahdi Marjani, Abbas Veshkini, Azin Tavakoli, Mohammad Javad Gharagozlou, Amir Niasari-Naslaji.   

Abstract

BACKGROUND: Injection of biomaterial to suburetral region, using minimally invasive procedure, has become an interesting topic for urologists to treat vesicoureteral reflux. The objective of this study was to evaluate the feasibility of injecting newly introduced calcium hydroxyl apatite to suburetral region, for treating an experimentally induced vesicoureteral reflux in dogs.
FINDINGS: Bilateral vesicoureteral refluxed (VUR) mixed breed dogs (n = 12; 10-15 kg live weight, 3-6 months of age) were selected for this study. The presence and grade of the reflux were determined using cystography. Accordingly, 6 dogs displayed grade 1 & 2 and the other 6 showed grade 3 & 4 bilateral VUR. Every single dog, with bilateral VUR, underwent endoscopic treatment and received an injection of calcium hydroxyl apatite (an Iranian made product) into the left (treated side) and an injection of the similar volume of normal saline in to the right (control side) subureteric space. One week, 3 and 6 months after treatment, cystography was performed. On each occasion, 4 dogs were euthanized by gas inhalation and biopsy samples were collected for histopathological study from ureter, bladder, kidney, lung and spleen in order to investigate the biomaterial migration into different organs. Data were analyzed using Chi-squared test. In control sides, radiographs confirmed the same grade of VUR, found at the initiation of the study. VUR was resolved in 100% (6/6) of Grade 1 & 2 and 83.33% (5/6) of Grade 3 & 4 in treated side. Therefore, the total success rate of this study was 91.67% (11/12). Macroscopic examination of the vesicouretral region of the treated side revealed a firm and consistent biomaterial mass at the site of injection. Histological findings confirmed inflammation at treated side. In contrast, there was no tissue reaction on control side. There was no evidence for biomaterial migration in macroscopic and microscopic observations in this study.
CONCLUSION: In the present study, a new biocompatible material produced a firm, consist and sustainable biomaterial mass in the suburetral region for treating vesicouretral reflux without any evidence of biomaterial migration.

Entities:  

Year:  2011        PMID: 21255445      PMCID: PMC3037325          DOI: 10.1186/1756-0500-4-14

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  16 in total

1.  Endoscopic treatment of vesicoureteral reflux with a self-detachable balloon system.

Authors:  A Atala; C A Peters; A B Retik; J Mandell
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

2.  Correction of experimentally produced vesicoureteric reflux in the piglet by intravesical injection of Teflon.

Authors:  P Puri; B O'Donnell
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-07

3.  [Preliminary results of endoscopic treatment of vesicoureteric reflux in children. Prospective comparative study of Deflux vs. Coaptite].

Authors:  Thierry Merrot; Isso Ouedraogo; Géraldine Hery; Pierre Alessandrini
Journal:  Prog Urol       Date:  2005-12       Impact factor: 0.915

4.  Endoscopic creation of reflux in the pig.

Authors:  A M Elbahnasy; A L Shalhav; D M Hoenig; K Maxwell; R S Figenshau; E M McDougall; R V Clayman
Journal:  J Endourol       Date:  1998-02       Impact factor: 2.942

5.  Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases.

Authors:  A Haferkamp; K Möhring; G Staehler; H J Gerner; J Dörsam
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder.

Authors:  A M Stenberg; A Sundin; B S Larsson; G Läckgren; A Stenberg
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

7.  A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results.

Authors:  A Stenberg; G Läckgren
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

8.  Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension.

Authors:  A Atala; W Kim; K T Paige; C A Vacanti; A B Retik
Journal:  J Urol       Date:  1994-08       Impact factor: 7.450

9.  Laparoscopic repair of vesicoureteral reflux utilizing the Lich-Gregoir technique in the pig model.

Authors:  E M McDougall; D A Urban; K Kerbl; R V Clayman; P Fadden; H D Royal; P S Chandhoke; A M Stone
Journal:  J Urol       Date:  1995-02       Impact factor: 7.450

10.  Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux.

Authors:  D P Smith; W E Kaplan; R Oyasu
Journal:  J Urol       Date:  1994-10       Impact factor: 7.450

View more
  2 in total

1.  Combination of calcium hydroxyapatite and autologous blood for endoscopic treatment of vesicoureteral reflux in children.

Authors:  Roozbeh Tanhaeivash; Abdol-Mohammad Kajbafzadeh; Atefeh Zeinoddini; Neda Khalili; Mona Vahidi Rad; Reza Heidari
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

2.  Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux.

Authors:  Ali Tekin; Ismail Yagmur; Sibel Tiryaki; Zafer Dokumcu; Ibrahim Ulman; Ali Avanoglu
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.